Drug intelligence / Profile preview

Unitorium

Development stage
Approved
Lead developer
Uni-Tech Pharmaceutical
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Unitorium is a brand-name generic version of the antibiotic ceftriaxone, manufactured by Uni-Tech Pharmaceutical (Pvt.) Ltd. It is a third-generation cephalosporin that exhibits broad-spectrum bactericidal activity against a wide range of Gram-positive and Gram-negative bacteria. The drug's mechanism of action involves the inhibition of bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). This binding prevents the final transpeptidation step of peptidoglycan synthesis, leading to the weakening of the cell wall and eventual osmotic lysis of the bacterium. Unitorium is primarily indicated for the treatment of serious infections, including lower respiratory tract infections, bacterial meningitis, septicemia, and urinary tract infections, and is also utilized for surgical prophylaxis.

Brand names
Unitorium
Other names
ceftriaxone
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on Unitorium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unitorium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call